Brief: Cogent Biosciences Enters Underwriting Agreement With Jefferies, J.P.Morgan LLC
13/11/2025 11:12
Alerts on Cogent Biosciences COGT.O entering an agreement to issue convertible notes are dated and have been withdrawn. For the correct alerts from November 11, click nTUAK7ZJJ STORY_NUMBER: nFWN3WP0IT STORY_DATE: November 13, 2025 STORY_TIME: 11:10 AM GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Cogent Biosciences
See all newsBrief: Cogent Biosciences - Enters Commercial Supply Agreement With Hovione On Sept 1, 2026 - SEC Filing
Brief: Cogent Biosciences - May Offer Up To $400 Million In Common Stock Through Guggenheim Securities
Cogent Biosciences Q2 net loss widens on higher expenses
Brief: Cogent Biosciences Q2 Net Income USD -96.405 Million
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's